{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:41:33Z","timestamp":1782456093638,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98788-1","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T19:16:00Z","timestamp":1752174960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interplay of kidney function and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Sylvia","family":"Mink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leiherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Cadamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hitzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Zitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Frick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H.","family":"Saely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fraunberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"98788_CR1","unstructured":"World Health Organization, WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/ (Accessed 20 September 2024)."},{"key":"98788_CR2","unstructured":"World Health Organization, Wastewater environmental surveillance, 2023. https:\/\/data.who.int\/dashboards\/covid19\/wastewater."},{"key":"98788_CR3","unstructured":"Centers for Disease Control and Prevention, COVID Data Tracker. https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home (Accessed 26 July 2024)."},{"key":"98788_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg, T. et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: A cohort study. Lancet 399, 1303\u20131312. https:\/\/doi.org\/10.1016\/S0140-6736(22)00462-7 (2022).","journal-title":"Lancet"},{"issue":"2022","key":"98788_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2011","unstructured":"Kovesdy, C. P. Epidemiology of chronic kidney disease: An update 2022. Kidney Int. Suppl. 12(2022), 7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003 (2011).","journal-title":"Kidney Int. Suppl."},{"key":"98788_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1053\/j.ajkd.2021.07.003","volume":"78","author":"EYM Chung","year":"2021","unstructured":"Chung, E. Y. M. et al. Incidence and outcomes of COVID-19 in people With CKD: A systematic review and meta-analysis. Am. J. Kidney Dis. 78, 804\u2013815. https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.003 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"98788_CR7","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s11255-023-03528-x","volume":"55","author":"H Schiffl","year":"2023","unstructured":"Schiffl, H. & Lang, S. M. Long-term interplay between COVID-19 and chronic kidney disease. Int. Urol. Nephrol. 55, 1977\u20131984. https:\/\/doi.org\/10.1007\/s11255-023-03528-x (2023).","journal-title":"Int. Urol. Nephrol."},{"key":"98788_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","volume":"52","author":"BM Henry","year":"2020","unstructured":"Henry, B. M. & Lippi, G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int. Urol. Nephrol. 52, 1193\u20131194. https:\/\/doi.org\/10.1007\/s11255-020-02451-9 (2020).","journal-title":"Int. Urol. Nephrol."},{"key":"98788_CR9","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s11255-020-02740-3","volume":"53","author":"R Cai","year":"2021","unstructured":"Cai, R. et al. Mortality in chronic kidney disease patients with COVID-19: A systematic review and meta-analysis. Int. Urol. Nephrol. 53, 1623\u20131629. https:\/\/doi.org\/10.1007\/s11255-020-02740-3 (2021).","journal-title":"Int. Urol. Nephrol."},{"key":"98788_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41581-022-00617-5","volume":"18","author":"N Babel","year":"2022","unstructured":"Babel, N., Hugo, C. & Westhoff, T. H. Vaccination in patients with kidney failure: lessons from COVID-19. Nat. Rev. Nephrol. 18, 708\u2013723. https:\/\/doi.org\/10.1038\/s41581-022-00617-5 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"98788_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 584, 430\u2013436. https:\/\/doi.org\/10.1038\/s41586-020-2521-4 (2020).","journal-title":"Nature"},{"key":"98788_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.963667","volume":"10","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews. Front. Public Health 10, 963667. https:\/\/doi.org\/10.3389\/fpubh.2022.963667 (2022).","journal-title":"Front. Public Health"},{"key":"98788_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.vaccine.2016.12.032","volume":"35","author":"E Zitt","year":"2017","unstructured":"Zitt, E. et al. Response to active hepatitis B vaccination and mortality in incident dialysis patients. Vaccine 35, 814\u2013820. https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.032 (2017).","journal-title":"Vaccine"},{"key":"98788_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12247575","author":"S Mink","year":"2023","unstructured":"Mink, S. & Fraunberger, P. Anti-SARS-CoV-2 antibody testing: Role and indications. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm12247575 (2023).","journal-title":"J. Clin. Med."},{"key":"98788_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13606","author":"S Mink","year":"2023","unstructured":"Mink, S. et al. Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortality. J. Intern. Med. https:\/\/doi.org\/10.1111\/joim.13606 (2023).","journal-title":"J. Intern. Med."},{"key":"98788_CR16","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-1487","author":"S Mink","year":"2024","unstructured":"Mink, S., Reimann, P. & Fraunberger, P. Prognostic value of anti-SARS-CoV-2 antibodies: A systematic review. Clin. Chem. Lab. Med. https:\/\/doi.org\/10.1515\/cclm-2023-1487 (2024).","journal-title":"Clin. Chem. Lab. Med."},{"key":"98788_CR17","doi-asserted-by":"publisher","first-page":"18326","DOI":"10.1038\/s41598-023-45700-4","volume":"13","author":"S Mink","year":"2023","unstructured":"Mink, S. et al. Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: A prospective cohort study. Sci. Rep. 13, 18326. https:\/\/doi.org\/10.1038\/s41598-023-45700-4 (2023).","journal-title":"Sci. Rep."},{"key":"98788_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ndt\/gfac307","volume":"38","author":"B Quiroga","year":"2023","unstructured":"Quiroga, B. et al. Humoral response after the fourth dose of the SARS-CoV-2 vaccine in the CKD spectrum: A prespecified analysis of the SENCOVAC study. Nephrol. Dial. Transplant 38, 969\u2013981. https:\/\/doi.org\/10.1093\/ndt\/gfac307 (2023).","journal-title":"Nephrol. Dial. Transplant"},{"key":"98788_CR19","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s40620-022-01245-9","volume":"35","author":"O Wand","year":"2022","unstructured":"Wand, O. et al. Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients. J. Nephrol. 35, 1479\u20131487. https:\/\/doi.org\/10.1007\/s40620-022-01245-9 (2022).","journal-title":"J. Nephrol."},{"key":"98788_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2307\/2529990","volume":"36","author":"JL Fleiss","year":"1980","unstructured":"Fleiss, J. L., Tytun, A. & Ury, H. K. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 36, 343\u2013346 (1980).","journal-title":"Biometrics"},{"key":"98788_CR21","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.chest.2020.03.010","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang, X. & Ji, X. Sample size estimation in clinical research: From randomized controlled trials to observational studies. Chest 158, S12\u2013S20. https:\/\/doi.org\/10.1016\/j.chest.2020.03.010 (2020).","journal-title":"Chest"},{"key":"98788_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-8587(21)00244-8","volume":"9","author":"C Steenblock","year":"2021","unstructured":"Steenblock, C. et al. COVID-19 and metabolic disease: Mechanisms and clinical management. Lancet Diabetes Endocrinol. 9, 786\u2013798. https:\/\/doi.org\/10.1016\/S2213-8587(21)00244-8 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"98788_CR23","doi-asserted-by":"publisher","first-page":"108651","DOI":"10.1016\/j.clim.2020.108651","volume":"224","author":"A Gasmi","year":"2021","unstructured":"Gasmi, A. et al. Interrelations between COVID-19 and other disorders. Clin. Immunol. 224, 108651. https:\/\/doi.org\/10.1016\/j.clim.2020.108651 (2021).","journal-title":"Clin. Immunol."},{"key":"98788_CR24","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104949","volume":"29","author":"R Pranata","year":"2020","unstructured":"Pranata, R., Huang, I., Lim, M. A., Wahjoepramono, E. J. & July, J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19\u2013systematic review, meta-analysis, and meta-regression. J. Stroke Cerebrovasc. Dis. 29, 104949. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104949 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"98788_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfac254","volume":"38","author":"RT Gansevoort","year":"2023","unstructured":"Gansevoort, R. T. et al. What should European nephrology do with the new CKD-EPI equation?. Nephrol. Dial. Transplant. 38, 1\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfac254 (2023).","journal-title":"Nephrol. Dial. Transplant."},{"key":"98788_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121581","author":"SP Kadatane","year":"2023","unstructured":"Kadatane, S. P., Satariano, M., Massey, M., Mongan, K. & Raina, R. The role of inflammation in CKD. Cells https:\/\/doi.org\/10.3390\/cells12121581 (2023).","journal-title":"Cells"},{"key":"98788_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107016","volume":"143","author":"S Mink","year":"2024","unstructured":"Mink, S. et al. Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort study. Int. J. Infect. Dis. 143, 107016. https:\/\/doi.org\/10.1016\/j.ijid.2024.107016 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"98788_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12050300","author":"M Espi","year":"2020","unstructured":"Espi, M., Koppe, L., Fouque, D. & Thaunat, O. Chronic kidney disease-associated immune dysfunctions: Impact of protein-bound uremic retention solutes on immune cells. Toxins https:\/\/doi.org\/10.3390\/toxins12050300 (2020).","journal-title":"Toxins"},{"key":"98788_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yexcr.2018.02.022","volume":"365","author":"CC Grabulosa","year":"2018","unstructured":"Grabulosa, C. C. et al. Chronic kidney disease induces inflammation by increasing Toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes. Exp. Cell Res. 365, 157\u2013162. https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.022 (2018).","journal-title":"Exp. Cell Res."},{"key":"98788_CR30","doi-asserted-by":"publisher","first-page":"2180373","DOI":"10.1155\/2018\/2180373","volume":"2018","author":"S Mihai","year":"2018","unstructured":"Mihai, S. et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J. Immunol. Res. 2018, 2180373. https:\/\/doi.org\/10.1155\/2018\/2180373 (2018).","journal-title":"J. Immunol. Res."},{"key":"98788_CR31","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.7150\/ijbs.80468","volume":"19","author":"C Yue","year":"2023","unstructured":"Yue, C. et al. Seeing the T cell immunity of SARS-CoV-2 and SARS-CoV: Believing the epitope-oriented vaccines. Int. J. Biol. Sci. 19, 4052\u20134060. https:\/\/doi.org\/10.7150\/ijbs.80468 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"98788_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ehjcvp\/pvz029","volume":"6","author":"H Drexel","year":"2020","unstructured":"Drexel, H. et al. The age of randomized clinical trials: Three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials. Eur. Heart J. Cardiovasc. Pharmacother. 6, 97\u2013103. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz029 (2020).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"98788_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00090-8","author":"F Muecksch","year":"2022","unstructured":"Muecksch, F. et al. Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: A serological analysis. The Lancet Microbe https:\/\/doi.org\/10.1016\/S2666-5247(22)00090-8 (2022).","journal-title":"The Lancet Microbe"},{"key":"98788_CR34","doi-asserted-by":"publisher","first-page":"1166059","DOI":"10.3389\/fimmu.2023.1166059","volume":"14","author":"E Paramithiotis","year":"2023","unstructured":"Paramithiotis, E. et al. Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development. Front. Immunol. 14, 1166059. https:\/\/doi.org\/10.3389\/fimmu.2023.1166059 (2023).","journal-title":"Front. Immunol."},{"key":"98788_CR35","unstructured":"World Health Organization, Tracking SARS-COV-2-variants. https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants (Accessed 18 July 2023)."},{"key":"98788_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1473-3099(22)00129-3","volume":"22","author":"DJ Sheward","year":"2022","unstructured":"Sheward, D. J. et al. Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: A cross-sectional study. Lancet Infect. Dis. 22, 813\u2013820. https:\/\/doi.org\/10.1016\/S1473-3099(22)00129-3 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"98788_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/jama.2022.12859","volume":"328","author":"HD Larkin","year":"2022","unstructured":"Larkin, H. D. Evolving omicron subvariants are more resistant to antibody therapy. JAMA 328, 518. https:\/\/doi.org\/10.1001\/jama.2022.12859 (2022).","journal-title":"JAMA"},{"key":"98788_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105768","volume":"221","author":"M Zur","year":"2024","unstructured":"Zur, M., Peselev, T., Yanko, S., Rotshild, V. & Matok, I. Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis. Antiviral Res. 221, 105768. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105768 (2024).","journal-title":"Antiviral Res."},{"key":"98788_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle, A., Laufs, U. & Liao, J. K. Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 120, 229\u2013243. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308537 (2017).","journal-title":"Circ. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98788-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:48:48Z","timestamp":1757220528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98788-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98788"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98788-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The local Institutional Review Board (IRB), Ethikkommission Vorarlberg, Roemerstrasse 15, A-6901 Bregenz, approved the study (EK-2-15\/2023-19) and waived the need for informed consent. The study was carried out in accordance with the Declaration of Helsinki of 1975 (revised 2013) and Good Clinical Research Practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"24978"}}